R & d- medical: biomedical (applied research/exploratory development)

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN272201200003I
Awardee
Awarding agency
Task orders
27 $75,052,201 obligated

Award facts

Combined order value
  • $75,052,201 Current, with exercised options
  • $79,315,955 Potential, with all options
Last date to order 100% complete
IDV ceiling 73% used
$102,500,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $102.5 million Indefinite Delivery Contract to Battelle Memorial Institute to provide research, development, testing, and evaluation services for vaccines and other biologics for infectious diseases. Under this contract, Battelle has been issued numerous cost-plus-fixed-fee and cost-plus-award-fee delivery orders to support NIAID's programs. These task orders, ranging from approximately $200,000 to over $7 million, involve activities such as:

  • Evaluating the immunogenicity and efficacy of vaccine candidates for diseases like plague, Zika, Ebola, and influenza in animal models
  • Conducting preparedness testing of NIAID priority vaccines in areas like general safety, toxicology, and neurovirulence
  • Providing clinical sample testing and assay development services to support vaccine research and development
  • Performing statistical meta-analysis on non-human primate control data to characterize animal models

Battelle, a large nonprofit research and development organization, frequently partners with specialized subcontractors like Envigo, Pointcross, and Southern Research Institute to leverage their capabilities in areas like animal testing, data management, and laboratory services. The contract does not include any set-aside designations, and the work is primarily performed at Battelle's facilities in Columbus, Ohio.

Task orders

Task order Ordering agency Obligated Awarded
The purpose of this task order is to design, conduct, and assess immunogenicity and efficacy of a plague vaccine… 75N93018F00027 National Institute of Allergy and Infectious Diseases (NIH) $906,320
Immunogenicity and efficacy testing of zikv vaccine candidates in nhps HHSN27200026 National Institute of Allergy and Infectious Diseases (NIH) $3,158,557
Preparedness for testing niaid priority vaccines in neurovirulence and reproductive toxicology studies HHSN27200025 National Institute of Allergy and Infectious Diseases (NIH) $2,026,617
Clinical sample testing for zika virus vaccines HHSN27200024 National Institute of Allergy and Infectious Diseases (NIH) $3,315,351
The purpose of this study is to perform statistical meta-analysis NHP control data to investigate the impact of… HHSN27200023 National Institute of Allergy and Infectious Diseases (NIH) $618,685
Non-GLP safety study of multivalent toxoid s. Aureus vaccine (IBT-V02) in nonhuman primates HHSN27200022 National Institute of Allergy and Infectious Diseases (NIH) $352,253
1200003I battelle memorial institute; to X21 obra--1 base task order funding; biod can 8470038; $274,639 HHSN27200021 National Institute of Allergy and Infectious Diseases (NIH) $1,335,707
Clinical sample testing for zika virus vaccines (task area 4) HHSN27200020 National Institute of Allergy and Infectious Diseases (NIH) $395,530
Development of assays and reagents for zika virus vaccines (task area 2) HHSN27200019 National Institute of Allergy and Infectious Diseases (NIH) $4,494,466
Evaluation of filovirus vaccines in a general use prophylaxis (GUP) immunogenicity and filovirus challenge studies HHSN27200018 National Institute of Allergy and Infectious Diseases (NIH) $4,626,893
Preparedness for testing niaid priority vaccines in general safety and toxicology studies HHSN27200017 National Institute of Allergy and Infectious Diseases (NIH) $2,221,940
Determination of plaque reduction neutralization titers HHSN27200016 National Institute of Allergy and Infectious Diseases (NIH) $265,960
1200003I battelle memorial institute; to X15OBRA--1: evaluation of ebolavirus and otherfilovirus vaccines in a novel… HHSN27200015 National Institute of Allergy and Infectious Diseases (NIH) $5,638,781
Evaluation of filovirus vaccines in a general use prophylaxis (GUP) immunogenicity and ebolavirus challenge studies… HHSN27200014 National Institute of Allergy and Infectious Diseases (NIH) $7,274,594
Evaluation of the immunogenicity of enterotoxigenic e. Coli antigens in combination with the double mutant lethal toxin… HHSN27200013 National Institute of Allergy and Infectious Diseases (NIH) $766,148
Evaluation of human tissue cross-reactivity of phase i clinical trial serum samples containing antibodies elicited by a… HHSN27200012 National Institute of Allergy and Infectious Diseases (NIH) $176,253
Evaluation of clinical samples from denvax clinical trial HHSN27200011 National Institute of Allergy and Infectious Diseases (NIH) $632,076
1200003I battelle memorial institute; eval & test serv for vaccines & other biologics; task order 10 base funding; biod… HHSN27200010 National Institute of Allergy and Infectious Diseases (NIH) $2,656,087
1200003I battelle memorial institute; eval & test serv for vaccines & other biologics; TO9 base funding; biod can… HHSN27200009 National Institute of Allergy and Infectious Diseases (NIH) $3,199,293
Efficacy testing of filovirus vaccines in non-human primates HHSN27200008 National Institute of Allergy and Infectious Diseases (NIH) $10,852,110
Preparedness for testing niaid priority vaccines in general safety and toxicology studies HHSN27200007 National Institute of Allergy and Infectious Diseases (NIH) $7,594,598
Secondary and tertiary outcomes of leishmania vaccine study 11-0031. HHSN27200006 National Institute of Allergy and Infectious Diseases (NIH) $537,975
Safety and toxicology: biodistribution study of pfspz challenge (7G8) HHSN27200005 National Institute of Allergy and Infectious Diseases (NIH) $461,715
Assessment of a simple adjuvant to enhance immunogenicity and efficacy of MVA and MVA-vectored vaccines HHSN27200004 National Institute of Allergy and Infectious Diseases (NIH) $1,303,415
The purpose of this task order is to evaluate the immunological responses of human samples collected from multiple… HHSN27200003 National Institute of Allergy and Infectious Diseases (NIH) $7,083,010
The purpose of this task order is to evaluate AVA in a general use prophylaxis (GUP) four weeks aerosol anthrax… HHSN27200002 National Institute of Allergy and Infectious Diseases (NIH) $1,516,522
R & d- medical: biomedical (applied research/exploratory development) HHSN27200001 National Institute of Allergy and Infectious Diseases (NIH) $1,641,345
Show all 27

Transactions

Action Obligated Date
Other Administrative Action P00017 $0
Supplemental Agreement for work within scope P00016 $0
Supplemental Agreement for work within scope P00015 $0
Supplemental Agreement for work within scope P00014 $0
Supplemental Agreement for work within scope P00013 $0
Supplemental Agreement for work within scope P00012 $0
Other Administrative Action P00011 $0
Supplemental Agreement for work within scope P00010 $0
Other Administrative Action P00009 $0
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope 6 $0
Supplemental Agreement for work within scope 5 $0
Supplemental Agreement for work within scope 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 · The purpose of this contract is to establish a niaid resource entitled "evaluation and testing services (ETS) for vaccines and other biologics for infectious… $0
Other Administrative Action 1 $0
Original award $0
Show all 18

Quick answers

Who was awarded contract HHSN272201200003I?

HHSN272201200003I was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 3, 2012.

How much is contract HHSN272201200003I worth?

Orders under HHSN272201200003I have obligated $75,052,201. Their combined potential value, with all options, is $79,315,955. HHSN272201200003I's own ceiling is $102,500,000.

How many orders have been placed under contract HHSN272201200003I?

27 orders have been placed under HHSN272201200003I, the latest on August 22, 2018.

Who can order from contract HHSN272201200003I?

HHSN272201200003I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN272201200003I competed?

The extent of competition for HHSN272201200003I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login